nexthera capital lp company profile  bloomberg feedback nexthera capital lp private company company profile sector financials industry asset management subindustry wealth management nexthera capital lp operates as an investment firm the company offers investment advisory and portfolio management services corporate information address  rd avenue suite  new york ny  united states phone  fax  from the web key executives daniel malek ceofounding partner ori hershkovitz founding partnercio timothy peter surzyn cfochief compliance officer sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data   nexthera capital fund ltd top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active nexthera capital fund ltd • grand cayman e • hedge fund how do i update this listing nexthera capital fund ltd is based out of grand cayman the firm last filed a form d notice of exempt offering of securities on  the filing was for a pooled investment fund hedge fund the notice included securities offered of equitypooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from nexthera capital fund ltd enter your email address below and choose submit your email cancel contact info nexthera capital fund ltd co maples corporate services limited grand cayman e    ky business phone   recent sec filings da filed on  da filed on  d filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining  da pooled investment fund hedge fund equitypooled investment fund interests indefinite  indefinite  da pooled investment fund hedge fund equitypooled investment fund interests indefinite  indefinite  d pooled investment fund hedge fund equitypooled investment fund interests indefinite  indefinite other issuers in filings name address no other issuers related parties included in filings name address relationship daniel malek subscription required director promoter julie ohara subscription required director matt auriemma subscription required director elevate your investments try it for free paratek pharmaceuticals nasdaqprtk stock price news  analysis paratek pharmaceuticals company profile nasdaqprtk company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about paratek pharmaceuticals nasdaqprtk paratek pharmaceuticals inc is a clinicalstage biopharmaceutical company the company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry its product candidates are the antibacterials omadacycline and sarecycline omadacycline is an antibiotic being developed for use as an empiric monotherapy option for patients suffering from serious communityacquired bacterial infections sarecycline is a tetracyclinederived compound designed for use in the treatment of acne and rosacea its other product candidates are tetracyclinederived molecular entities and are designed to utilize the recognized immunemodulation antiinflammatory and other beneficial properties of the tetracycline class these research stage programs include product candidates for multiple sclerosis spinal muscular atrophy systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases industry sector and symbol sector medical industry bio therapeutic drugs subindustry pharmaceuticals symbol nasdaqprtk cusip m web wwwparatekpharmacom capitalizationmarket cap  millionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio naforeward pe ratio pe growth sales  book valueannual revenue price  sales book value  per shareprice  book  profitabilityebidta return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  shsbeta short ratio    frequently asked questions for paratek pharmaceuticals nasdaqprtk what is paratek pharmaceuticals stock symbol paratek pharmaceuticals trades on the nasdaq under the ticker symbol prtk how were paratek pharmaceuticals earnings last quarter paratek pharmaceuticals inc nasdaqprtk issued its quarterly earnings data on thursday may th the company reported  earnings per share eps for the quarter topping analysts consensus estimates of  by  the business earned  million during the quarter view paratek pharmaceuticals earnings history where is paratek pharmaceuticals stock going where will paratek pharmaceuticals stock price be in   analysts have issued year price objectives for paratek pharmaceuticals shares their predictions range from  to  on average they expect paratek pharmaceuticals stock price to reach  in the next twelve months view analyst ratings for paratek pharmaceuticals what are analysts saying about paratek pharmaceuticals stock here are some recent quotes from research analysts about paratek pharmaceuticals stock  cantor fitzgerald analysts commented oasis study met all of its primary and secondary endpoints required to support approval for this indication by the fda and ema this represents the third positive phase  registration study of omadacycline the other two were skin and pneumonia   according to zacks investment research paratek pharmaceuticals inc is a biopharmaceutical company the company focuses on the discovery development and commercialization of therapeutics that treat infectious disease agents the companys lead product candidate omadacycline is a tetracyclinederived antibiotic being developed for use as a firstline monotherapy for serious communityacquired bacterial infections where antibiotic resistance is of concern for treating physicians its second product candidate wc  is a tetracyclinederived compound designed for use in the treatment of acne and rosacea paratek pharmaceuticals inc formerly known as transcept pharmaceuticals inc is based in united states    robert w baird analysts commented though sarecycline is not a key driver it provides a potential source of nondilutive financing and further validates parateks ability to develop a once daily well tolerated tetracyclinederived antibiotic looking ahead we expect continued momentum with focus on key upcoming data readouts from two phase  studies of omadacycline in q supporting filing in h and we reiterate our outperform rating  who are some of paratek pharmaceuticals key competitors some companies that are related to paratek pharmaceuticals include clinigen group plc clin xencor xncr amarin corporation plc amrn insmed insm forward pharma as fwp acorda therapeutics acor neuroderm ndrm aduro biotech adro omeros corporation omer synergy pharmaceuticals sgyp ascendis pharma as asnd insys therapeutics insy five prime therapeutics fprx keryx biopharmaceuticals kerx retrophin rtrx aclaris therapeutics acrs flexion therapeutics flxn and ziopharm oncology ziop who are paratek pharmaceuticals key executives paratek pharmaceuticals management team includes the folowing people michael f bigham cpa chairman of the board chief executive officerevan loh md president chief operating officer chief medical officer directordouglas w pagan chief financial officerwilliam m haskel senior vice president general counsel corporate secretaryregina d paglia senior vice president  human resourcesjeanne jew senior vice president  business developmentevan tzanis senior vice president  clinical development and clinical operationsrajesh padmanabhan vice president  information technologystephen villano md vice president  clinical and medical affairsadam woodrow vice president and chief commercial officer who owns paratek pharmaceuticals stock paratek pharmaceuticals stock is owned by many different of institutional and retail investors top institutional shareholders include omega fund management llc  interwest venture management co  nea management company llc  russell investments group ltd  appleton partners inc ma  and fox run management llc  company insiders that own paratek pharmaceuticals stock include adam woodrow douglas w pagan evan loh fund iv lp omega and michael bigham view institutional ownership trends for paratek pharmaceuticals who bought paratek pharmaceuticals stock who is buying paratek pharmaceuticals stock paratek pharmaceuticals stock was purchased by a variety of institutional investors in the last quarter including russell investments group ltd appleton partners inc ma and fox run management llc company insiders that have bought paratek pharmaceuticals stock in the last two years include evan loh fund iv lp omega and michael bigham view insider buying and selling for paratek pharmaceuticals how do i buy paratek pharmaceuticals stock shares of paratek pharmaceuticals can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is paratek pharmaceuticals stock price today one share of paratek pharmaceuticals stock can currently be purchased for approximately  marketbeat community rating for paratek pharmaceuticals nasdaq prtkcommunity ranking   out of    outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about paratek pharmaceuticals and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for paratek pharmaceuticals nasdaqprtk how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  buy ratings  strong buy ratingconsensus ratingbuy score consensus price target   upside analysts ratings history for paratek pharmaceuticals nasdaqprtk show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailshc wainwrightboost price targetpositive  buy  highcantor fitzgeraldset price targetbuyhighraymond james financial incinitiated coveragestrongbuy  strongbuyhighguggenheimset price targetbuymediumbtig researchboost price targetbuy  mediumrobert w bairdreiterated ratingoutperformmediumwedbushreiterated ratingoutperform  outperformhighleerink swannreiterated ratingbuynaladenburg thalmann financial servicesboost price targetbuy  nadata available from  forward earnings earnings history for paratek pharmaceuticals nasdaqprtkearnings history by quarter for paratek pharmaceuticals nasdaq prtkdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsq  millionviewlistenq  millionviewlistenviewnaviewnaqviewlistenqviewlistenq billionviewnaq million millionviewna millionviewnaq million millionviewnaq viewnaq million millionviewnadata available from  forward estimates earnings estimates for paratek pharmaceuticals nasdaqprtk eps consensus estimate  eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q q q q q data provided by zacks investment research dividends dividend history by quarter for paratek pharmaceuticals nasdaq prtkannouncedperiodamountyieldexdividend daterecord datepayable datespecialdata available from  forward insider trades insider trading and institutional ownership history for paratek pharmaceuticals nasdaqprtkinsider ownership percentage institutional ownership percentage insider trades by quarter for paratek pharmaceuticals nasdaqprtktransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailsadam woodrowvpsell  douglas w pagancfosell  evan lohcoosell  michael bighamchairmansell  douglas w pagancfosell  douglas w pagancfosell  evan lohcoosell  michael bighamchairmansell  fund iv lp omegamajor shareholderbuy  michael bighamceobuy  evan lohcmobuy  hbm healthcare investments camajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  roumell asset management llcmajor shareholdersell  data available from  forward headlines headline trends for paratek pharmaceuticals nasdaqprtk latest headlines for paratek pharmaceuticals nasdaqprtk source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineparatek puts skin in the infection game  seeking alphaseekingalphacom  july  at  pmparatek pharmaceuticals inc nasdaqprtk expected to announce earnings of  per sharewwwamericanbankingnewscom  july  at  pmbreakfast technical briefing on biotech stocks  aurinia pharma esperion therapeutics paratek pharma and verastemwwwprnewswirecom  july  at  amparatek pharmaceuticals inc breached its  day moving average in a bearish manner  prtkus  july  financeyahoocom  july  at  amparatek antibiotic candidates phase iii data favorablefinanceyahoocom  july  at  amparatek pharmaceuticals to report second quarter  financial results and provide update on clinical progress on august  financeyahoocom  july  at  amparatek pharmaceuticals prtk says phase  study of oralonly dosing of omadacycline met all primary and   streetinsidercomwwwstreetinsidercom  july  at  amparatek announces phase  study of oralonly dosing of omadacycline met all primary and secondary fda and ema efficacy endpoints in acute bacterial skin infectionsfinanceyahoocom  july  at  amparatek pharmaceuticals inc nasdaqprtk stock rating reaffirmed by cantor fitzgeraldwwwamericanbankingnewscom  july  at  pmparatek pharmaceuticals inc prtk given average rating of buy by brokerageswwwamericanbankingnewscom  july  at  amis the options market predicting a spike in paratek prtk stockfinanceyahoocom  july  at  amnotable monday option activity newr stt prtk  nasdaqwwwnasdaqcom  july  at  amparatek announces inducement grants under nasdaq listing rule cfinanceyahoocom  july  at  pmevan loh sells  shares of paratek pharmaceuticals inc prtk stockwwwamericanbankingnewscom  july  at  pminsider selling paratek pharmaceuticals inc nasdaqprtk chairman sells  shares of stockwwwamericanbankingnewscom  july  at  pmdouglas w pagan sells  shares of paratek pharmaceuticals inc nasdaqprtk stockwwwamericanbankingnewscom  july  at  pmparatek pharmaceuticals inc prtk vp adam woodrow sells  shareswwwamericanbankingnewscom  july  at  pmbiotech movers paratek opko endofinanceyahoocom  july  at  am million in sales expected for paratek pharmaceuticals inc prtk this quarterwwwamericanbankingnewscom  june  at  amzacks analysts expect paratek pharmaceuticals inc prtk will announce earnings of  per sharewwwamericanbankingnewscom  june  at  pmcantor fitzgerald reaffirms overweight rating for paratek pharmaceuticals inc prtkwwwamericanbankingnewscom  june  at  pmparatek pharmaceuticals inc prtk cfo douglas w pagan sells  shareswwwamericanbankingnewscom  june  at  pmparatek pharmaceuticals inc prtk given average recommendation of buy by analystswwwamericanbankingnewscom  june  at  ametfs with exposure to paratek pharmaceuticals inc  june  financeyahoocom  june  at  amparatek pharmaceuticals inc – value analysis nasdaqprtk  june  financeyahoocom  june  at  pmparatek pharmaceuticals inc to participate in jmp securities life science conference  nasdaqwwwnasdaqcom  june  at  amparatek pharmaceuticals inc to participate in jmp securities life science conferencefinanceyahoocom  june  at  amparatek pharmaceuticals inc breached its  day moving average in a bullish manner  prtkus  june  financeyahoocom  june  at  amnew microbiology data reinforce activity of parateks omadacycline   globenewswire press releaseglobenewswirecom  june  at  pmnew microbiology data reinforce activity of paratek’s omadacycline against pathogens of importance in respiratory skin and urinary tract infectionsfinanceyahoocom  june  at  pm million in sales expected for paratek pharmaceuticals inc prtk this quarterwwwamericanbankingnewscom  june  at  am eps expected for paratek pharmaceuticals inc prtk this quarterwwwamericanbankingnewscom  june  at  pmshort interest in paratek pharmaceuticals inc prtk rises by wwwamericanbankingnewscom  may  at  pmparatek pharmaceuticals inc prtk receives average rating of buy from analystswwwamericanbankingnewscom  may  at  amparatek pharmaceuticals to present new data from omadacycline development program at asm microbe   globenewswire press releasewwwglobenewswirecom  may  at  pmparatek pharmaceuticals the  antibiotic stock to buy now  seeking alphaseekingalphacom  may  at  pmparatek pharmaceuticals inc prtk research coverage started at raymond james financial incwwwamericanbankingnewscom  may  at  pmanalysts offer predictions for paratek pharmaceuticals incs fy earnings prtkwwwamericanbankingnewscom  may  at  pm million in sales expected for paratek pharmaceuticals inc prtk this quarterwwwamericanbankingnewscom  may  at  am analysts expect paratek pharmaceuticals inc prtk will announce earnings of  per sharewwwamericanbankingnewscom  may  at  pmparatek announces completion of enrollment for oralonly omadacycline phase  skin study topline data expected in midjulyfinanceyahoocom  may  at  amwedbush equities analysts boost earnings estimates for paratek pharmaceuticals inc prtkwwwamericanbankingnewscom  may  at  amparatek pharmaceuticals inc prtk pt set at  by cantor fitzgeraldwwwamericanbankingnewscom  may  at  amanalysts set expectations for paratek pharmaceuticals incs q  earnings prtkwwwamericanbankingnewscom  may  at  pmparatek pharmaceuticals inc prtk releases quarterly earnings results beats estimates by  epswwwamericanbankingnewscom  may  at  pmtodays research reports on arrowhead pharmaceuticals and paratek pharmaceuticals post earningsfinanceyahoocom  may  at  amparatek pharmaceuticals inc prtkseekingalphacom  may  at  amparatek pharmaceuticals inc reports first quarter  financial results and provides clinical updatefinanceyahoocom  may  at  aminvestor network paratek pharmaceuticals inc to host earnings callfinanceyahoocom  may  at  amparatek pharmaceuticals inc reports first quarter  financial results and provides clinical update  yahoo financefinanceyahoocom  may  at  pm social chart paratek pharmaceuticals prtk chart for wednesday july   this page was last updated on  by marketbeatcom staff nexthera capital lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active nexthera capital lp httpwwwnextheracapitalcom • new york ny • investment advisor • hedge fund how do i update this listing nexthera capital is based out of new york nexthera capital is a hedge fund with  clients and discretionary assets under management aum of  form adv from  their last reported f filing for q  included  in managed f securities and a top  holdings concentration of  nexthera capitals largest holding is pfizer inc with shares held of  whalewisdom has at least  fs and  dg filings in our database for nexthera capital summary f holdings ind managers inv advisor info dg insider form  download f summary to excel download f summary to excel create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from nexthera capital lp enter your email address below and choose submit your email cancel  top buys name change pfe pfizer inc  gsk glaxosmithkline plc  vrtx call vertex pharmaceutic  ndrm neuroderm ltd  azn call astrazeneca plc adr   top sells name change nvs novartis ag ads  azn astrazeneca plc adr  hznp horizon pharma inc  shpg shire plc ads  alny alnylam pharmaceuti   f holdings summary stock port pfe pfizer inc  shpg shire plc ads  azn call astrazeneca plc adr  celg celgene corp  gsk glaxosmithkline plc adr  see all holdings  f activity market value  million prior market value  million new purchases stocks additional purchases stocks sold out of stocks reduced holdings in stocks top  holdings  turnover   turnover alt   time held top quarters time held top quarters time held all quarters  turnover is calculated by taking the  of new holdings initial purchases  the  of positions sold out of not just reduced divided by the total  of holdings for the quarter  alt turnover is calculated by taking either the total mv of new purchases or the mv of securities sold whichever is less divided by the total mv of the fund  f sector allocation over time fund metrics you are limited to the prior  quarters of f filings subscribe to whalewisdom to view all filing data for nexthera capital lp portfolio performance top  equalweighted holdings last updated on  performance for q   performance last  quarters  performance metrics stats are not available for the latest quarter backtester use whalewisdoms backtester tool to test how a hypothetical portfolio would have performed with different investment strategies research one or more filers performance and then optimize their portfolios to match your own investment goals start with one of our predefined groups or create your own view the backtesting whitepaper and the getting started page for additional help take a tour save changes to tracked backtest saving generate report at least one fund must be selected before running a backtest  ending sector allocation quarter to view current combined fdg q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings refresh advanced export download csv download excel xlsx download tsv click to see additional filters security types shares calls puts principal changes in holdings new position added to position reduced position closed out position no change ranking is in the top minimum  of shares stock ticker is etf yesno refresh edit columns shares are split adjusted × report an error your name optional your email optional error to report or any other commentsrequired cancel click here to report any possible errors with this listing f filings available   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required × csv export module this will schedule a job to export all requested f holdings data for this filer when completed an email will be sent to the email address you specify containing a link to download the zip file of the csv files you requested output type output all f holdings into a single csv file output all f holdings into separate csv files per quarter columns to include filer name stock name stock ticker quarter date type of security current shares held current market value previous shares held previous market value current  of portfolio previous  of portfolio current rank previous rank change in shares type of change sector f quarters to include       email address to send data to cancel schedule export view last form adv compilation report on record nexthera capital lp classified as hedge fund  third avenue suite  new york ny     country united states business phone     fax     professional investment advisor data sec registration as  large advisory firm form of organization limited partnership organized in de number of employees  other business activities advisor feescompensation percentage of assets under managementperformancebased fees amount of client funds and securities  total number of clients  amount of client funds and securities by related persons total number of clients from related persons disclosures httpwwwnextheracapitalcom data above was derived from sec filings schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free ori hershkovitz  cofounder at nexthera capital lp news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink ori hershkovitz cofounder at nexthera capital lp overview in the news relationships paths education career history boards  committees ori hershkovitz cofounder at nexthera capital lp overview age  born  notable companies nexthera capital lp board seats  number of relationships this person is connected to  people in the news see more hedgeweek march   nexthera adds former citadel portfolio manager globenewswire september   medigus receives nasdaq letter regarding audit committee compliance the san diego uniontribune march   auspex sold to israeli drugmaker teva san diego pharmaceutical company develops treatments for movement disorders relationships see details doron birger advisor at landmark ventures israel inc chistopher rowland chief executive officer  director at medigus ltd elina frenkel ronen former chief financial officer at orek paper ltd ron grupel former chief internal auditor at teva pharmaceutical industries ltd yair rabionowitch former managing partner at bavly  co suzana nahumzilberberg chief executive officer at biolight life sciences ltd israel makov chairman at gesher theater eitan machover cofounder  managing general partner at meditech partners inc nissim darvish senior managing director at orbimed advisors llc anat naschitz managing director at orbimed advisors llc see  more listings with relsci professional start my free trial ➤ see  more paths to ori hershkovitz ori hershkovitz you connections via relationship science ori hershkovitz sync your contacts to see how you can connect with ori hershkovitz start my free trial ➤ see more educational background   tel aviv university tel aviv university tau hebrew   universitat tel aviv is a public university located in ramat aviv tel aviv israel with nearly  students tau is israels largest university located in israels cultural financial and industrial core tel aviv university is a major center of teaching and research comprising  faculties  schools  departments and  research institutes and centers its origins go back to  when three research institutes – the tel aviv school of law and economics the institute of natural sciences and the institute of jewish studies – joined together to form the university of tel aviv initially operated by the tel aviv municipality the university was granted autonomy in  the university also maintains academic supervision over the center for technological design in holon the new academic college of tel avivyaffo and the afeka college of engineering in tel aviv the wise observatory is located in mitzpe ramon career history cofounder   current nexthera capital lp nexthera capital lp is an american private company located in new york ny with subsidiaries in cayman islands the firm provides investment advice it was founded in  by ori hershkovitz and daniel malek daniel malek has been the ceo since then analyst tenure unconfirmed ilanot batucha mutual funds ltd fund advisor prior sphera global healthcare management lp boards  committees corporate boards ▾ director    medigus ltd medigus ltd is a medical device company which engages in the research and development manufacture and sale of endosurgical tools and instruments it specializes in the area of gastroesophageal reflux disease its product muse system offers minimal invasive endoscopic devices and procedures for gastric surgery the company was founded by elazar sonnenschein on december   and is headquartered in omer israel director    micromedic technologies ltd micromedic technologies ltd is engaged in diagnostics of cancer the companys principal activity is licensing translating and commercializing new promising earlydetection and monitoring biomarkers for various autoimmune clinical conditions the company was incorporated in  may  and is headquartered in tel aviv israel director prior insuline medical ltd insuline medical ltd engages in the research and development of insulin treatment methods it includes insupatch and insupad product lines the insupatch product line is a device for insulin pump users the insupad product line is a device for injection users the company was founded by gabriel bitton ehudmoshe gilboa and ron ezra nagar on february   and is headquartered in petach tikva israel other affiliations ori hershkovitz is affiliated with nexthera capital lp ilanot batucha mutual funds ltd sphera global healthcare management lp medigus ltd micromedic technologies ltd insuline medical ltd youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ neuroderm ltd ndrm rating lowered to market perform at raymond james financial inc  daily political home aboutcontact columnists privacy policy headlines politics nation world issues economy finance neuroderm ltd  get news  ratings daily enter your email address below to get the latest news and analysts ratings for neuroderm ltd with our free daily email newsletter follow dailypolitical     latest news neuroderm ltd ndrm rating lowered to market perform at raymond james financial inc costco wholesale corporation nasdaqcost rating reiterated by cowen and company microsoft corporation msft cut to “hold” at zacks investment research consol energy inc nysecnx stock rating upgraded by zacks investment research qad inc qada lifted to “buy” at zacks investment research pennymac mortgage investment trust nysepmt upgraded at zacks investment research metropolitan life insurance co ny sells  shares of xenia hotels  resorts inc nysexhr select income reit nasdaqsir shares sold by metropolitan life insurance co ny metropolitan life insurance co ny has  million position in kornferry international kfy paloma partners management co has  stake in horizon pharma plc hznp york capital management global advisors llc boosts stake in monsanto company mon bank of new york mellon corporation the bk stake cut by nomura holdings inc bank of america corp de boosts position in rogers corporation rog bank of america corp de has  million position in harsco corporation hsc bank of america corp de lowers position in ambarella inc nasdaqamba bank of america corp de has  million stake in simmons first national corporation sfnc the finish line inc nasdaqfinl shares bought by bank of america corp de enterprise products partners lp epd position lowered by weiss multi strategy advisers llc iivi incorporated nasdaqiivi position raised by state street corp state street corp purchases  shares of franklin street properties corp fsp neuroderm ltd ndrm rating lowered to market perform at raymond james financial inc july th    comments  filed under  by patrick bannon filed under analyst articles  us  finance tweet neuroderm ltd nasdaqndrm was downgraded by stock analysts at raymond james financial inc from an “outperform” rating to a “market perform” rating in a research note issued on monday marketbeatcom reports they presently have a  target price on the biotechnology company’s stock raymond james financial inc’s price objective would indicate a potential upside of  from the company’s current price other analysts also recently issued research reports about the company deutsche bank ag started coverage on neuroderm in a research note on friday july st they issued a “buy” rating and a  price target on the stock roth capital set a  price target on neuroderm and gave the stock a “buy” rating in a research note on wednesday june th jefferies group llc restated a “buy” rating and issued a  price target on shares of neuroderm in a research note on monday april th oppenheimer holdings inc restated a “hold” rating on shares of neuroderm in a research note on sunday may th finally zacks investment research downgraded neuroderm from a “buy” rating to a “hold” rating in a research note on wednesday april th one analyst has rated the stock with a sell rating three have issued a hold rating and six have issued a buy rating to the company neuroderm currently has a consensus rating of “buy” and a consensus target price of  neuroderm nasdaq ndrm opened at  on monday the stock has a  day moving average price of  and a day moving average price of  neuroderm has a month low of  and a month high of  the company’s market cap is  billion neuroderm nasdaqndrm last posted its quarterly earnings results on thursday may th the biotechnology company reported  earnings per share for the quarter topping the consensus estimate of  by  on average analysts predict that neuroderm will post  eps for the current fiscal year trademark violation warning this story was reported by daily political and is owned by of daily political if you are viewing this story on another website it was illegally stolen and republished in violation of united states  international trademark and copyright law the legal version of this story can be accessed at httpswwwdailypoliticalcomneurodermltdndrmratingloweredtomarketperformatraymondjamesfinancialinchtml a number of hedge funds have recently modified their holdings of the stock oppenheimer  co inc acquired a new stake in shares of neuroderm during the first quarter valued at approximately  nationwide fund advisors acquired a new stake in shares of neuroderm during the first quarter valued at approximately  hightower advisors llc acquired a new stake in shares of neuroderm during the first quarter valued at approximately  bank of montreal can acquired a new stake in shares of neuroderm during the first quarter valued at approximately  finally nj state employees deferred compensation plan acquired a new stake in shares of neuroderm during the first quarter valued at approximately  institutional investors and hedge funds own  of the company’s stock about neuroderm neuroderm ltd is an israelbased clinicalstage pharmaceutical company the company is engaged in developing treatments for central nervous system cns disorders primarily parkinson’s disease as well as other cns diseases the company’s parkinson’s disease product candidates are drugdevice combination products with devices and varying levodopa ldcarbidopa cd or apomorphine concentrations and dosages receive news  ratings for neuroderm ltd daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for neuroderm ltd and related companies with marketbeatcoms free daily email newsletter  comment on this post click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation latest news jeff sessions spoke of resigning after tensions increase with trump president trump’s tweets complicate already complicated week world leaders very critical of paris agreement decision by trump aide to president trump resigns with more expected scudclass missile launched by north korea  dailypolitical llc  all rights reserved privacy policy  about  columnists  contact nexthera adds former citadel portfolio manager news home advertising board and executive moves energy health care hedge funds m  a private equity technology powered by nexthera adds former citadel portfolio manager email linkedin facebook google tweet reddit permalink mar    hedgeweek board and executive moves nexthera capital a hedge fund manager focused on global therapeutics has appointed rael mazansky as director of researchworking with nextheras cofounder and cio ori hershkovitz pictured mazansky will help drive nextheras investment strategy of seeking high riskadjusted returns from the healthcare and therapeutics sectors   we are excited to hire an individual with a long and impressive history in healthcare investing rael will strengthen our team as we continu sign up for unrestricted access to  subscription services by signing up you agree to our terms of use privacy policy and the lexisnexis terms  conditions already have an account click here to login relsci news  alerts gets you  free articles a month from top subscription outlets like the financial times new york times and washington post competitive business intelligence through daily data updates custom feeds on target highvalue individuals companies industries and topics delivered straight to your inbox related news feeds nexthera capital lp hedge funds board and executive moves in hedge funds alumni of tel aviv university create your own custom news feed mentioned entities ori hershkovitz rael mazansky daniel malek surveyor capital ltd nexthera capital lp see how you can reach these people and organizations youve found a premium relsci pro feature connect to individuals and organizations in this story upgrade to relsci pro to easily sync your contacts and see how you can reach the people and organizations featured in this article start my free trial ➤ still not convinced check out our full listing of features here not now are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft capital fund ltd  money az  web results aol search skip over navigation search the web web images images capital fund  capital fund ad · simplicom​capital fund capital fund visit today  find more results fund capital  fund capital  fund capital for sale ad · wwwshoppingnet​fund capital fund capital for sale find our lowest possible price capital funding  looksmart  results for capital funding ad · wwwlooksmartcom​capital funding results for capital funding get the look smart on looksmartcom look here more info good results quick business loans  get approved  funded quickly ad · kabbagecom get approved  funded quickly a rated by bbb get started now kabbagecom is rated rated  out of   reviews instant working capital business credit line  to k biz loan searches related tocapital fund ltd capital fund management venture capital funds capital funds vs operating funds american funds capital group global capital partners fund limited hud capital fund web results d capital investment fund ltd wwwdcapitalfundcom we identify promising investment opportunities while operating with transparency efficiency and effectiveness in a regulated environment steadview capital fund ltd form d filed july   formdfindthecompanycomlsteadviewcapitalfundltd research private fundraising by steadview capital fund ltd find the details of their july   form d filing and compare it to their past filings the fund  d capital investment fund ltd wwwdcapitalfundcomthefund governing law and fund structure d capital investment fund limited is a private company limited by shares established under the companies law cap  mediatrix capital fund ltd mediatrixcapitalfundcom this is a page excerpt it will be displayed for search results india capital growth fund wwwindiacapitalgrowthcom india capital growth fund limited is a closed ended investment company registered and incorporated in guernsey the company was established to take advantage of long  home  india capital httpswwwindiacapitalcom legal privacy terms of use india capital opportunities™ india institutional fund™   india capital management ltd all rights reserved investment management  investment funds  new capital newcapitalfundscom new capital is a specialist investment house with highconviction strategies designed to produce longterm outperformance for clients capital funds group  entrepreneurs solution to money and  capitalfundsgroupcom capital funds group ltd has been in business for  years first in the us now serving you from canada were specialists in financial services and consulting to a  capital funding  investopedia wwwinvestopediacomtermsccapitalfundingasp a companys capital funding consists of both debt  the business uses this money for operating capital  or it might fund businesses at any stage home  new capital funds newcapitalfundcom new capital fund lp was founded in  and is one of the leading venture capital firms in the state of wisconsin we focus on making  capital fund  capital fund ad · simplicom​capital fund capital fund visit today  find more results fund capital  fund capital  fund capital for sale ad · wwwshoppingnet​fund capital fund capital for sale find our lowest possible price capital funding  looksmart  results for capital funding ad · wwwlooksmartcom​capital funding results for capital funding get the look smart on looksmartcom look here more info good results quick business loans  get approved  funded quickly ad · kabbagecom get approved  funded quickly a rated by bbb get started now kabbagecom is rated rated  out of   reviews instant working capital business credit line  to k biz loan searches related tocapital fund ltd capital fund management venture capital funds capital funds vs operating funds american funds capital group global capital partners fund limited hud capital fund next answers asia frontier capital ltd headquarters awards afc asia frontier fund was named new fund launch of the year in the  acquisition international ma awards in  asia more capital dynamics asia’s first global investment house locations and funds capital dynamics australia ltd a global fund manager primarily managing the i capital more donors capital fund donors capital fund dcf is a nonprofit united states donoradvised charity that distributes grants to conservative and libertarian organizations more search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network